GWAS Data Merging via Quality Control and Ontology Alignment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Genome-wide association studies (GWAS) face challenges in combining data from multiple studies due to differences in phenotype labeling and sample sizes, leading to incomplete or inaccurate meta-analyses, and existing methods require laborious relabeling or regathering of data to achieve consistent results.

Innovation Solution

The proposed techniques involve quality control measures, such as variant-level and study-level quality metrics, to filter and merge genetic data from different studies, and the use of ontologies to compare and align phenotypes, ensuring only high-quality data is included in combined analyses, thereby reducing redundant calculations and conserving computational resources.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If data from multiple GWAS studies are combined without quality control, then the sample size increases, but the data quality and reliability deteriorate

Engineering Contradiction:
Improvesample sizeVSAvoiddata quality
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent applies quality control metrics to GWAS studies before they are included in meta-analysis. This preliminary filtering ensures that only studies meeting predefined quality thresholds are combined, thereby maintaining data reliability while achieving increased sample size through legitimate data aggregation.

Inventive Principle:
Principle #10Preliminary action

2Manufacturing precision

If phenotype labeling is standardized across studies, then data consistency improves, but the time and computational resources required for relabeling increase

Engineering Contradiction:
Improvedata consistencyVSAvoidtime for relabeling
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent introduces phenotype similarity scoring as an intermediary mechanism to assess whether phenotypes across different studies are sufficiently similar for combination. This scoring system uses ontology-based comparison to determine compatibility without requiring complete relabeling of all datasets, thereby achieving data consistency while minimizing the time and computational resources needed for standardization.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Adaptability or versatility

If all GWAS studies are included in meta-analysis regardless of size, then comprehensive coverage is achieved, but computational resources are wasted on studies with negligible contribution

Engineering Contradiction:
Improvecomprehensive coverageVSAvoidcomputational resources
Core Design Contradiction:
Adaptability or versatilityVSUse of energy by moving object

Solution Approach 1:

The patent establishes minimum sample size thresholds as a filtering parameter for GWAS studies included in meta-analysis. By changing the inclusion criteria from comprehensive coverage to threshold-based selection, the system achieves optimal balance between comprehensive coverage and computational efficiency, eliminating waste on studies with negligible contribution while maintaining representativeness.

Inventive Principle:
Principle #35Parameter changes

4Reliability

If quality control metrics are applied to filter studies, then data reliability improves, but the number of studies available for analysis decreases

Engineering Contradiction:
Improvedata reliabilityVSAvoidnumber of studies
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent applies quality control metrics at the study level rather than requiring all studies to meet uniform stringent criteria. This localized quality assessment allows individual studies to be evaluated on their own merits, enabling inclusion of diverse studies with varying qualities while maintaining overall data reliability through selective combination of studies that meet minimum thresholds.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20240428884A1Analyzing and Merging Data from Genome-Wide Association Studies
Publication Date: 2024.12.26 23ANDME RESEARCH LLC
  • US20240428884A1 patent drawing
  • US20240428884A1 patent drawing
  • US20240428884A1 patent drawing

AI summary

Example embodiments relate to analyzing and merging data from genome-wide association studies. An example embodiment includes a method. The method includes receiving, by a processor from a memory, a candidate data set including data from a genetic study conducted within a population. The data from the genetic study includes a plurality of gene variants determined within the population. The method also includes removing one or more of the plurality of gene variants from the candidate data set in order to generate a revised candidate data set based on one or more variant-level quality metrics. Further, the method includes determining whether the revised candidate data set satisfies one or more study-level quality metrics. Additionally, the method includes establishing data set metadata based on whether the revised candidate data set satisfies one or more study-level quality metrics. Further, the method includes storing, within the memory, the data set metadata.